Thanks to our longstanding presence and proven business model, we hold a stable position in the U.S. and Canada, consistently generating strong margins and cash flows. We are driving profitable growth by expanding our industrial product offerings while continuing to improve our operational efficiency.
The market for pharmaceutical-grade anhydrous dextrose is expanding in the United States due to an aging population and the rising incidence of chronic disease. Anhydrous dextrose is a critical component in IV solutions for hydration, nutrition, drug delivery and also acts as an inert binder, filler and stabilizer in tablet manufacturing.
Thanks to our long history of producing our CERELOSE® brand USP-grade dextrose in compliance with rigorous standards, Ingredion possesses the expertise and operational capabilities necessary to efficiently respond to market developments and establish itself as a leading supplier within the health care industry.
Starch is the future of packaging. Starch-based packaging is more sustainable than fossil-fuel polymers used today. It avoids forever chemicals and microplastics, while offering versatile options for coatings, adhesives and binders that enhance strength and reduce weight.
Drawing on our knowledge of plant science, starch chemistry, and packaging processes, Ingredion has become a leader in packaging innovation. To meet rising demand, Ingredion is investing $50 million to modernize and expand our Cedar Rapids facility, which produces industrial starch for the papermaking and corrugated packaging industries. Boosting capacity and improving efficiency will allow us to deliver differentiated value to our customers in the papermaking and packaging sectors.
